|
Baseline Clinical Characteristics and Disease Burden in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH): Updated Analysis From the International PNH Registry
|
Jul 2020
|
Annals of Hematology
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
|
Rigosertib in Combination With Azacitidine in Patients With Myelodysplastic Syndromes or Acute Myeloid Leukemia: Results of a Phase 1 Study
|
Jul 2020
|
Leukemia Research
|
acute myeloid leukemia (AML), myelodysplastic syndromes (MDS)
|
|
Therapy-related Myelodysplastic Syndromes Deserve Specific Diagnostic Sub-Classification and Risk-Stratification-An Approach to Classification of Patients With t-MDS
|
Jun 2020
|
Leukemia
|
myelodysplastic syndromes (MDS)
|
|
High Serum Ferritin Levels in Newly Diagnosed Patients With Myelodysplastic Syndromes Are Associated With Greater Symptom Severity
|
Jun 2020
|
International Journal of Hematology
|
myelodysplastic syndromes (MDS)
|
|
Characterization of Myelodysplastic Syndromes (MDS) With T-cell Large Granular Lymphocyte Proliferations (LGL)
|
Jun 2020
|
Leukemia
|
myelodysplastic syndromes (MDS)
|
|
Iron Overload Alters the Energy Metabolism in Patients With Myelodysplastic Syndromes: Results From the Multicenter FISM BIOFER Study
|
Jun 2020
|
Scientific Reports
|
myelodysplastic syndromes (MDS)
|
|
A Case Series of Post-Transplantation Cyclophosphamide in Unrelated Donor Hematopoietic Cell Transplantation for Aplastic Anemia
|
Jun 2020
|
Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation
|
aplastic anemia
|
|
Myelodysplastic/myeloproliferative Neoplasm, Unclassifiable (MDS/MPN-U): More Than Just a "Catch-All" Term?
|
Jun 2020
|
Best practice & research. Clinical haematology
|
myelodysplastic syndromes (MDS), myeloproliferative neoplasms (MPN)
|
|
Cyclosporine Enhances the Sensitivity to Lenalidomide in MDS/AML in Vitro
|
Jun 2020
|
Experimental Hematology
|
acute myeloid leukemia (AML), myelodysplastic syndromes (MDS)
|
|
Myelodysplastic Syndromes: A Review of Therapeutic Progress Over the Past 10 Years
|
Jun 2020
|
Expert Review of Anticancer Therapy
|
myelodysplastic syndromes (MDS)
|
